This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Spondyloepiphyseal Dysplasia척추골단형성이상

📋 Contents and key points
ItemDetails
A. Classification codesICD-10: Q77.7 (Spondyloepiphyseal dysplasia) | Special Copayment Reduction: V228 (rare disease)
B. SynonymsSpondyloepiphyseal dysplasia (SED congenita, SED tarda), Spondyloepiphyseal dysplasia tarda, Congenital spondyloepiphyseal dysplasia
C. Adult onsetVery low likelihood of first presenting in adulthood — SED congenita is diagnosed at birth; SED tarda presents in late childhood to adolescence. Cervical instability is a risk in adults as well.
1. History1966: Spranger and Wiedemann describe SED congenita → 1994: COL2A1 variants identified (congenita) → 1999: SEDL/TRAPPC2 gene (tarda) identified.
2. CausesSED congenita: COL2A1 variants (autosomal dominant). SED tarda: SEDL (TRAPPC2) gene (X-linked recessive). Abnormal structure and function of type II collagen.
3. GeneticsCOL2A1 (12q13.11, AD): broad variant spectrum (SED to Stickler to hypochondrogenesis 2). TRAPPC2 (Xp22.2-p22.1, XL recessive): abnormal COPII vesicle transport.
4. General epidemiologySED congenita: about 1 in 100,000 births. SED tarda: 1 in 150,000 male births. Estimated at several thousand people worldwide.
5. PathophysiologySED congenita: COL2A1 variant → instability of the type II collagen triple helix → abnormal cartilage, vitreous, and intervertebral disc matrix. SED tarda: TRAPPC2 variant → abnormal COPII vesicle transport → impaired chondrocyte secretion.
6. SymptomsShort-trunk dwarfism, platyspondyly, cervical instability (atlantoaxial instability, odontoid hypoplasia), retinal detachment, myopia, hip dysplasia, premature degenerative arthritis.
7. SignsThoracolumbar kyphoscoliosis, coxa vara, limited cervical flexion, radiographic platyspondyly, odontoid hypoplasia, delayed or abnormal ossification of the epiphyses.
8. ScreeningPrenatal ultrasound (short-trunk shortening, narrow thorax). COL2A1/TRAPPC2 molecular genetic analysis in high-risk families. Cervical spine MRI after birth.
9. DiagnosisClinical (short-trunk dwarfism + ophthalmologic abnormalities + cervical instability) + radiographic (platyspondyly) + COL2A1/TRAPPC2 confirmation. Differential: Kniest, Stickler, SED tarda.
10. TreatmentCervical instability stabilization (atlantoaxial fusion). Correction of hip dysplasia. Scoliosis surgery. Prophylactic laser for retinal detachment. Management of early arthritis. Physical therapy.
11. PrognosisNormal life expectancy is possible (with management of cervical instability). Main risks: cervical cord injury, retinal detachment, early arthritis. SED tarda is milder than SED congenita.
12. PreventionGenetic counseling, prenatal diagnosis, PGT. Regular cervical spine evaluation (MRI). Regular ophthalmologic examination of the retina. Avoid contact sports (patients with cervical instability).
13. ReferencesSpranger J, Wiedemann HR. Z Kinderheilkd 1966; Tiller GE et al. Am J Hum Genet 1995; Gedeon AK et al. Nat Genet 1999 … and 7 others

1. History

Spondyloepiphyseal dysplasia (SED) is a collective term for a heterogeneous group of hereditary skeletal dysplasias affecting both the spine and the epiphyses of the long bones. Clinically it is broadly divided into two main forms—congenita and tarda—each with different genes and modes of inheritance.

The first independent description of SED congenita was made in 1966 by Jürgen Spranger and Hans-Rudolf Wiedemann of Germany. They described a group of patients with short-trunk dwarfism, platyspondyly, myopia, and retinal detachment from birth as an independent disease distinct from existing achondroplasia. The radiographic characteristics were subsequently defined in detail by Maroteaux et al. In 1994, when Tiller et al. established variants in the COL2A1 (type II collagen) gene as the cause of SED congenita, SED congenita came to be placed as a member of the type II collagenopathy spectrum of osteochondrodysplasias.

SED tarda is an X-linked recessive form, mainly with a 'late-onset' course in which symptoms appear in boys after school age. In 1994, Gedeon et al. and Melnick et al. independently identified the association of the disease with the Xp22 chromosomal region, and in 1999 Gedeon et al. identified the SEDL (TRAPPC2) gene. Later studies showed that TRAPPC2 is a component of the COPII vesicle transport complex between the endoplasmic reticulum (ER) and Golgi apparatus and plays an important role in protein secretion in chondrocytes.

As understanding of the type II collagen-related disease spectrum has advanced, it has been established that SED congenita is the moderate phenotype, with a continuous distribution within the same COL2A1 variant spectrum extending to lethal achondrogenesis, severe Kniest dysplasia, and mild Stickler syndrome type I. This reflects a complex genotype–phenotype correlation in which a broad clinical spectrum arises depending on the location and type of COL2A1 variants.


2. Causes

Spondyloepiphyseal dysplasia is divided mainly into two genetic causes.

SED congenita — COL2A1 variants: Caused by heterozygous pathogenic variants of the COL2A1 gene located on the long arm of chromosome 12 (12q13.11). COL2A1 encodes the α1 chain of type II collagen, and type II collagen is a major structural protein in cartilage (hyaline and elastic cartilage), the nucleus pulposus of the intervertebral disc, the vitreous humor, and the inner ear. The most common type of variant is glycine substitution (missense variants of glycine residues within the Gly-Xaa-Yaa repeat sequence), which interferes with formation of the type II collagen triple helix structure. The mode of inheritance is autosomal dominant.

SED tarda — TRAPPC2 (SEDL) variants: Manifests in males owing to hemizygous pathogenic variants of the TRAPPC2 (SEDL) gene located on the short arm of the X chromosome (Xp22.2-p22.1). TRAPPC2 is a subunit of the TRAPPC (trafficking protein particle complex) multiprotein complex responsible for protein transport from the endoplasmic reticulum to the Golgi apparatus, and is essential for the secretory pathway (COPII vesicle transport) of matrix proteins such as collagen and proteoglycans in chondrocytes. Female carriers are mostly asymptomatic, but may show some symptoms depending on skewed X inactivation.

A variety of clinical spectra arise depending on the severity and location of COL2A1 variants. A spectrum from lethal phenotypes (achondrogenesis type II, hypochondrogenesis type II) to SED congenita, Kniest dysplasia, spondyloepimetaphyseal dysplasia (SEMD), Stickler syndrome type I (centered on mild ophthalmologic abnormalities), and early-onset osteoarthritis arises from variants in the same gene. This is collectively called 'type II collagenopathy'.


3. Genetics

The COL2A1 gene is located on the long arm of chromosome 12 (12q13.11) and is a gene about 30 kb long composed of 54 exons. The type II collagen α1 chain consists of 1,487 amino acids, and three identical chains form a triple helix to make up type II collagen. Because periodic placement of glycine residues in the Gly-Xaa-Yaa repeat sequence is essential for forming the triple helix structure, missense variants of glycine residues within this repeat sequence (e.g., G→C, G→A, G→D) severely interfere with triple helix formation.

The mode of inheritance of SED congenita is autosomal dominant. About half of patients arise from de novo mutations, and the rest are transmitted from an affected parent in an autosomal dominant manner. The type and location of the variant determine clinical severity, and glycine substitution variants closer to the C-terminus of the triple helix tend to cause a more severe phenotype, although there are many exceptions. Splicing variants and large deletions also cause varied phenotypes.

The TRAPPC2 gene is located on the short arm of the X chromosome (Xp22.2-p22.1) and is composed of 6 exons. The TRAPPC2 protein is a subunit consisting of 140 amino acids and is a component of the TRAPP (transport protein particle) I complex. SED tarda is X-linked recessive, and female carriers give birth to males with hemizygous variants while themselves mostly asymptomatic. Various variants, including nonsense, frameshift, and splicing variants, have been reported in TRAPPC2.

In genotype–phenotype correlation, some prediction is possible for COL2A1 variants, but phenotypic variability is large, so it is difficult to predict the clinical severity of an individual patient accurately. Most TRAPPC2 variants produce the SED tarda phenotype, and no association with other syndromes has been reported. Molecular genetic testing is essential for confirming the diagnosis, family counseling, and differentiation from other diseases within the same COL2A1 spectrum.


4. General epidemiology

The incidence of SED congenita is estimated at about 1–3 per 100,000 births, and although it is inherited in an autosomal dominant manner, about 50% arise from de novo mutations, so it can occur without a family history. The incidence of SED tarda is estimated at about 1 in 150,000 male births. Both diseases occur in all ethnic groups worldwide, with no regional differences in frequency.

Because of the mode of inheritance (AD), 50% of the children of an affected parent are affected in SED congenita, so when there is an affected parent the number of patients in the family may be large. However, the proportion of de novo mutations is high (about 50%), so it is also common for it to occur without a family history. SED tarda is X-linked recessive and manifests only in males (hemizygous), and female carriers are mostly asymptomatic. 50% of the sons of a carrier woman are affected.

Considering the entire spectrum of COL2A1-related osteochondrodysplasias, SED congenita is one of the most commonly diagnosed COL2A1 phenotypes. Stickler syndrome type I is much more common than SED congenita (about 1/7,500–1/20,000) and is caused by variants in the same COL2A1 gene, but is a milder phenotype dominated by ophthalmologic symptoms. In Korea, SED is an ultra-rare disease, with very few patients registered under Special Copayment Reduction (V228), and it is often reported in the literature only as case reports.


5. Pathophysiology

SED congenita — COL2A1 mechanism: In normal cartilage, type II collagen is the major structural protein of the hyaline cartilage matrix and a component of the extracellular matrix (ECM) secreted mainly by chondrocytes. COL2A1 variants—particularly glycine residue substitutions in the triple helix region—cause structural instability of the type II collagen triple helix. Defective collagen molecules accumulate in the endoplasmic reticulum (ER), triggering the unfolded protein response (UPR) and promoting chondrocyte apoptosis. Even when secreted, collagen fiber formation within the matrix is incomplete, impairing the structural integrity of the cartilage matrix.

Weakening of the cartilage matrix disrupts the normal columnar organization of growth plate chondrocytes and reduces the efficiency of proliferation, differentiation, and hypertrophy, so growth of the spine and the epiphyses of the long bones is preferentially affected. Vertebral bodies grow by endochondral ossification, and dysfunction of the vertebral cartilage plate due to type II collagen deficiency causes platyspondyly. The vitreous humor also has type II collagen as a main component, so with COL2A1 variants the risks of vitreous degeneration, high myopia, and retinal detachment increase. Type II collagen is also expressed in the inner ear, and sensorineural hearing loss occurs in some patients.

SED tarda — TRAPPC2 mechanism: TRAPPC2 (the SEDL protein) is a component of the COPI/COPII vesicle transport pathway responsible for protein transport from the endoplasmic reticulum to the Golgi apparatus. In chondrocytes, large amounts of ECM proteins such as collagen and proteoglycans must be secreted, so the efficiency of this secretory pathway is particularly important. In TRAPPC2 deficiency, COPII vesicle transport is inhibited, secretion of ECM proteins by chondrocytes decreases, and protein accumulation in the ER triggers the UPR, causing chondrocyte dysfunction. This leads to reduced growth of the vertebral bodies and epiphyses, but because SED tarda shows a late-onset course with symptoms appearing in late school age, it is suggested that partial preservation of TRAPPC2 function or compensatory mechanisms of other secretory pathways may exist.

Mechanism of cervical instability: The stability of the atlantoaxial joint depends on development of the odontoid process (dens) and ligamentous structures. In SED, atlantoaxial instability (AAI) occurs owing to odontoid hypoplasia and vertebral body abnormalities, and this is a direct cause of cervical cord compression. On cervical flexion, the odontoid process compresses the cervical cord, and an emergency that can lead to quadriplegia, bladder dysfunction, and even death may occur.


6. Symptoms

SED congenita and SED tarda differ in clinical features and are described separately.

Symptoms of SED congenita: Distinct short-trunk dwarfism is present from birth. Limb length is relatively less shortened, and the trunk appears markedly short compared with the limbs. Adult height ranges from about 84 to 128 cm (median about 107 cm). The thorax is narrow and neonatal respiratory failure may occur. Myopia is very common, and the risk of severe myopia (–10 diopters or more) and retinal detachment is high. Retinal detachment can lead to blindness if not properly treated, so regular ophthalmologic follow-up is essential. Cervical instability and odontoid hypoplasia accompany, and the resulting spinal cord compression is a serious complication. Hip dysplasia (coxa vara) is common, and genu valgum or varus also occurs. Sensorineural hearing loss accompanies in some patients.

Symptoms of SED tarda: X-linked recessive, manifesting mainly in males. It is normal at birth, and after school age (5–10 years) the rate of height gain slows and trunk shortening becomes gradually evident. Adult height is about 120–155 cm, milder than SED congenita. Low back pain and joint pain are the main symptoms, and premature osteoarthritis occurs in the 20s–30s, particularly in the hips and spine. Retinal detachment and myopia are not as severe in SED tarda as in SED congenita but may accompany. Cervical instability is less severe than in SED congenita but requires attention.


7. Signs

Physical signs: In SED congenita, trunk shortening is evident and thoracolumbar kyphoscoliosis is observed. Decreased breath sounds due to thoracic narrowing may occur. Cervical tenderness and limited flexion, limb weakness (with cervical cord compression), hyperreflexia, and bladder dysfunction appear as complications of cervical instability. Limited hip adduction and flexion and gait abnormality due to coxa vara are observed.

Radiographic signs: The most characteristic finding on whole-body skeletal radiography is platyspondyly, in which the vertebral bodies are flattened and oval or wedge-shaped deformity is observed. Odontoid process hypoplasia or absence is confirmed on lateral cervical spine radiographs. Delayed or irregular ossification of the epiphyses is seen in the femoral head, humeral head, and others. A triangular shape of the ilium may be observed on coronal radiographs. Hip radiographs confirm coxa vara and acetabular dysplasia.

Ophthalmologic findings: Slit-lamp examination shows vitreous syneresis, lattice degeneration, and retinal tears. Refraction testing measures severe myopia. Fundoscopy may show retinal detachment and peripheral retinal degeneration.

Hearing tests: Pure-tone audiometry confirms sensorineural hearing loss (mainly high-frequency) in some patients, and regular hearing evaluation is recommended.


8. Screening

Universal screening of the general population for SED is not performed; systematic evaluation is carried out in high-risk groups and clinically suspected patients.

Prenatal ultrasound: Severe SED congenita can be suspected on prenatal ultrasound by short-trunk limb shortening and a narrow thorax. However, mild to moderate SED congenita has nonspecific prenatal ultrasound findings, so prenatal diagnosis may be difficult. When there is an affected parent (with a confirmed COL2A1 variant), active prenatal ultrasound and molecular genetic testing should be performed.

Molecular genetic prenatal diagnosis: In the pregnancy of an affected parent or a carrier mother (SED tarda), fetal DNA is obtained by chorionic villus sampling or amniocentesis and analyzed for COL2A1 (SED congenita) or TRAPPC2 (SED tarda) variants.

Postnatal clinical screening: When short-trunk dwarfism, respiratory limitation, and thoracolumbar kyphosis are present at birth, suspect SED congenita and perform whole-body skeletal radiography and molecular genetic testing. Cervical spine MRI is performed early after birth to evaluate odontoid malformation and atlantoaxial instability. SED tarda is suspected from decreased height growth and low back pain after school age, and because it is X-linked recessive, identifying a family history (affected maternal grandfather or maternal uncle) in boys is important.


9. Diagnosis

The diagnosis of SED is made in steps of characteristic clinical and radiographic findings followed by molecular genetic confirmation.

Clinical diagnostic criteria (SED congenita): ① short-trunk dwarfism (at birth or in infancy), ② platyspondyly (radiograph), ③ odontoid hypoplasia (radiograph), ④ ophthalmologic abnormalities (myopia, retinal detachment, or vitreous degeneration), ⑤ hip dysplasia. A clinical diagnosis is made from the combination of these findings and confirmed by COL2A1 molecular genetics.

Clinical diagnostic criteria (SED tarda): In males, decreased height gain after school age, low back pain, trunk shortening, radiographic platyspondyly, and epiphyseal abnormalities. Confirmed by TRAPPC2 molecular genetics. A family history (X-linked pedigree) helps the diagnosis.

Radiographic examination: Whole-body skeletal radiography (skeletal survey) is essential, evaluating platyspondyly, epiphyseal irregularity, pelvic and hip abnormalities, and odontoid morphology. Lateral cervical spine flexion–extension radiographs are used to measure atlantoaxial instability (atlantodens interval >5 mm). Cervical spine MRI evaluates for spinal cord compression.

Molecular genetic confirmation: COL2A1 NGS (can differentiate within the COL2A1 spectrum, including SED congenita, Stickler type I, and Kniest) or TRAPPC2 analysis (SED tarda). A comprehensive skeletal dysplasia panel NGS is advantageous for differential diagnosis.

Differential diagnosis: Kniest dysplasia (COL2A1; greater knee joint enlargement and joint abnormalities than SED congenita, with more specific radiographic findings). Stickler syndrome type I (COL2A1; centered on ophthalmologic abnormalities, with mild skeletal abnormalities). Spondyloepimetaphyseal dysplasia (SEMD; the limbs are also affected). SED tarda — compared in form, with milder spinal abnormalities than SED congenita and less severe ophthalmologic and cervical complications.


10. Treatment

There is no fundamental treatment for SED, and multidisciplinary management for preventing complications and preserving function is the core of treatment.

Management of cervical instability: When atlantoaxial instability is confirmed, prophylactic cervical fusion (C1-C2 or occiput-C2) is often recommended regardless of the presence of neurological symptoms. Cervical protection with a cervical collar is needed before surgery. All activities that subject the cervical spine to flexion impact, such as contact sports, diving, and trampolines, are strictly prohibited. If signs of cervical cord compression (quadriplegia, gait abnormality, voiding dysfunction) appear, immediate neurosurgical evaluation and surgery are needed.

Ophthalmologic management: Because the risk of retinal detachment is high, regular ophthalmologic examination (at 1–2-year intervals) is essential. When lattice degeneration or retinal tears are found, retinal detachment is prevented by prophylactic laser photocoagulation. Myopia is corrected with glasses or contact lenses. If retinal detachment occurs, immediate ophthalmic surgery (scleral buckling, vitrectomy) is needed.

Hip treatment: When coxa vara or acetabular dysplasia is present, femoral valgus osteotomy or acetabular correction surgery is considered. Total hip replacement may be needed in adults with advanced premature osteoarthritis.

Scoliosis treatment: Bracing for mild cases; posterior spinal fusion is performed for progressive cases.

Pain management and rehabilitation: For joint pain from premature osteoarthritis, NSAIDs (after risk–benefit assessment), acetaminophen, physical therapy, and aquatic exercise are used. Weight management reduces joint load.


11. Prognosis

The life expectancy in SED is similar to that of the general population if acute spinal cord injury due to cervical instability is prevented. Intellectual ability is normal, and participation in school, work, and social life is possible. However, chronic pain, joint complications, and ophthalmologic complications affect quality of life.

Cervical complications: The most serious prognostic factor. When cervical cord compression occurs, quadriplegia and respiratory failure may result, and immediate surgical decompression and fixation are needed. Prophylactic cervical fixation can greatly reduce this risk. In patients with SED congenita, cervical stabilization during general anesthesia is especially important, and the anesthesia team must be informed of the cervical instability before surgery.

Ophthalmologic complications: Retinal detachment is an important complication of SED congenita, and its incidence can be reduced by prophylactic laser treatment and regular follow-up. If it occurs, immediate treatment can preserve vision. Regular ophthalmologic follow-up through adulthood is essential.

Joint complications: Premature osteoarthritis occurs in the hips and spine, especially in the 20s–40s in men with SED tarda, causing long-term decline in joint function and pain. Aggressive joint protection (weight management, low-impact exercise), pain management, and ultimately joint replacement improve prognosis.

Comparison of SED congenita and tarda: SED congenita carries the risk of more serious complications such as neonatal respiratory failure, cervical instability, and retinal detachment, and requires more intensive management. SED tarda has a milder course overall, but premature osteoarthritis and low back pain are the main factors reducing quality of life.


12. Prevention

Primary prevention — genetic counseling and genetic testing: When an individual with SED congenita (AD) or a female carrier of SED tarda plans a pregnancy, genetic counseling and prenatal diagnosis and preimplantation genetic testing (PGT) are discussed. Because 50% of the children of a patient with a confirmed COL2A1 variant are affected, excluding affected embryos by PGT is presented as an option. Because 50% of the sons of a female SED tarda carrier are affected, prenatal TRAPPC2 analysis or PGT is useful.

Prevention of cervical complications: Immediately on diagnosis, evaluate atlantoaxial instability with cervical radiographs and MRI, and if instability is confirmed, discuss with a neurosurgeon whether to perform prophylactic cervical fixation. Prohibit contact sports, diving, and impact exercise in all SED patients, and apply a cervical stabilization protocol for surgery and general anesthesia. Monitor progression of spinal cord compression with regular cervical MRI (at 1–2-year intervals).

Prevention of retinal detachment: Patients with SED congenita should have an ophthalmologic examination at least once a year, and prophylactic laser photocoagulation is performed when lattice degeneration is found. Educate patients to seek emergency ophthalmologic care if ophthalmic symptoms (sudden visual field defect, flashes of light, increased floaters) occur.

Joint protection: Weight management, recommended low-impact exercise (swimming, cycling), and regular joint evaluation to detect premature osteoarthritis and treat it early.


13. References

  1. Spranger JW, Wiedemann HR. Dysplasia spondyloepiphysaria congenita. Helv Paediatr Acta. 1966;21(6):598-611. PMID: 5997783.

  2. Tiller GE, Polumbo PA, Weis MA, et al. Dominant mutations in the type II collagen gene, COL2A1, produce spondyloepimetaphyseal dysplasia, Strudwick type. Nat Genet. 1995;11(1):87-89. DOI: 10.1038/ng0995-87. PMID: 7550322.

  3. Gedeon AK, Colley A, Dorkins H, et al. Identification of the gene (SEDL) causing X-linked spondyloepiphyseal dysplasia tarda. Nat Genet. 1999;22(4):400-404. DOI: 10.1038/11976. PMID: 10431245.

  4. Becker J, Semler O, Gilissen C, et al. Exome sequencing identifies truncating mutations in human SETBP1 within the Schinzel-Giedion syndrome spectrum and phenotypic expansion of COL2A1 mutations. Am J Hum Genet. 2011;88(6):739-747. DOI: 10.1016/j.ajhg.2011.04.013. PMID: 21600187.

  5. Anderson IJ, Goldberg RB, Marion RW, et al. Spondyloepiphyseal dysplasia congenita: genetic linkage to type II collagen (COL2AI). Am J Hum Genet. 1990;46(5):896-901. PMID: 2339693.

  6. Posey KL, Hecht JT. The role of cartilage oligomeric matrix protein (COMP) in skeletal disease. Curr Drug Targets. 2008;9(10):869-877. DOI: 10.2174/138945008785909293. PMID: 18855617.

  7. Mundlos S, Olsen BR. Heritable diseases of the skeleton. Part I: Molecular insights into skeletal development—transcription factors and signaling pathways. FASEB J. 1997;11(2):125-132. DOI: 10.1096/fasebj.11.2.9039954. PMID: 9039954.

  8. Kannu P, Bateman J, Savarirayan R. Clinical phenotypes associated with type II collagen mutations. J Paediatr Child Health. 2012;48(2):E38-43. DOI: 10.1111/j.1440-1754.2010.01979.x. PMID: 21199034.

  9. Rimoin DL, Lachman RS. Genetic disorders of the osseous skeleton. In: McKusick's Heritable Disorders of Connective Tissue, 5th ed. 1993. [Classic reference]

  10. Bonafe L, Cormier-Daire V, Hall C, et al. Nosology and classification of genetic skeletal disorders: 2015 revision. Am J Med Genet A. 2015;167A(12):2869-2892. DOI: 10.1002/ajmg.a.37365. PMID: 26394607.